Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 1

Optimal timing for antihypertensive dosing: focus on valsartan

       
Total article views   HTML views PDF downloads Totals
6,725 Dovepress* 6,725+ 2,003 8,728
Totals 6,725 2,003 8,728
*Since 15 March 2007
+Since July 2016

View citations on Google Scholar